Invention Grant
US08663651B2 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation
有权
具有用于免疫调节的CXCR4超激动剂活性的T-140肽类似物
- Patent Title: T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation
- Patent Title (中): 具有用于免疫调节的CXCR4超激动剂活性的T-140肽类似物
-
Application No.: US12520811Application Date: 2007-12-23
-
Publication No.: US08663651B2Publication Date: 2014-03-04
- Inventor: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant: Amnon Peled , Michal Begin , Katia Beider , Michal Abraham
- Applicant Address: IL Nes Ziona
- Assignee: Biokine Therapeutics Ltd.
- Current Assignee: Biokine Therapeutics Ltd.
- Current Assignee Address: IL Nes Ziona
- International Application: PCT/IL2007/001598 WO 20071223
- International Announcement: WO2008/075371 WO 20080626
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K38/00 ; A61K39/00 ; A61K39/38 ; A61K39/385 ; A01N61/00
Abstract:
The present invention is directed to novel therapeutic uses of T-140 analog peptides and compositions comprising same. Specifically, the invention provides compositions and methods useful for immunomodulation.
Public/Granted literature
- US20100143334A1 T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR IMMUNOMODULATION Public/Granted day:2010-06-10
Information query
